Novavax Inc. (NVAX) Downgraded by Vetr Inc.

Novavax Inc. (NVAX) Downgraded by Vetr Inc.


They currently have a $7.86 price target on the biopharmaceutical company's stock. Vetr 's price objective would suggest a potential upside of 11.97% from the company's current price.



from Biotech News